Eat more and pile on weight. Eat less and loose weight. Or is it that simple? HOW should we eat to stay fit and away from obesity? A talk with investigative science & health journalist and co-founder of the non-profit Nutrition Science Initiative (NuSI.org) Gary Taubes, to discuss the relationship of obesity & calories, the current state of nutrition research, and mull over some controversial concepts in nutrition science. Mr. Gary Taubes is a recipient of the Robert Wood Johnson Foundation Investigator Award in Health Policy Research.
A mothers immune system is altered during pregnancy so that the fetus is not rejected by her body and is allowed to grow. When this balance goes awry, the immune system may become the cause of a miscarriage or multiple miscarriages. We talked to Dr. Jeffrey Braverman, a world leader in reproductive immunology, about the role of immune system in recurrent miscarriages. Dr. Braverman discussed about various immunity related conditions or issues that may be the cause of recurrent miscarriages, and also highlighted the advances in the diagnosis and management of immune related pregnancy complications.
Multiple Myeloma is the second most common cancer of the blood and is largely incurable. A recent study has found that a specific gene mutation can increase the risk of developing myeloma six to nine fold. The lead author of the study and Professor of Medicine and Genetic Medicine at Weill Cornell, Dr. Steven M. Lipkin talked to the panel on predisposition to multiple myeloma and role of precision medicine.
Dr. Steven Lipkin
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Earlier this year it was predicted that the majority of trials would integrate at least some features of DCT technology, starting with trial design. Experts suggested that the discussion would revolve around which aspects of a…
Virtual or remote clinical trials (decentralized clinical trials or DCT) became a necessity during COVID-19. In the beginning of 2023 it was predicted that the majority of trials will integrate at least some features of the…
TrialX xPAND is enabling decentralized clinical research here on earth and in space. In addition to helping clinical trial investigators collect study data remotely, we are proud to support pre and post flight data collection for historic space missions such as…